Ongoing/Recruiting Trails
Diabetic Kidney disease Clinical trial (Pro Kidney)
The Diabetic Kidney disease Clinical Trial Protocol is a Phase 3 clinical trial aimed at delaying the progression of kidney disease, in addition to providing standard-of-care treatment for patients with diabetic kidney disease (diabetic nephropathy).
IgA Nephropathy
This Protocol will evaluate the efficacy of an investigational medication, in addition to your standard-of-care medications, to reduce proteinuria in adult participants with IgAN, with the goal is to delaying the progression of kidney disease.
Membranous Nephropathy
This protocol aims to provide the efficacy of an investigational medication, in addition to your standard medications, in reducing proteinuria and delay the progress of kidney disease.
FSGS (Focal Segmental Glomerulosclerosis)
This Protocol will evaluate the efficacy of an investigational medication, with the goal to reduce proteinuria and delaying the progression of kidney disease.
